** UnitedHealth Group UNH.N reported fourth-quarter profit on Thursday that beat analysts' estimates
** However, UNH posted annual medical care ratio - percentage of premiums spent on medical care - of 85.5%, compared to expectation of 84.96%
MEDICAL COSTS A CONCERN
** BofA Global Research ("buy," PT: $675) says UNH has strong position vs Medicare Advantage peers; sees more potential for MLR recovery in 2026
** Oppenheimer ("outperform," PT: $640) says UNH's stock performance should improve, but rising medical costs could be a hurdle
** Leerink Partners ("outperform," PT: $675) says, "our thesis remains anchored to diminishing controversies with accelerating growth and margin expansion into 2026 against a less bad Medical Advantage backdrop"
** RBC ("outperform," PT: $655) says cost trend increase is largely one-time, while outlook for healthcare service utilization is stabilizing
(Reporting by Rashika Singh in Bengaluru)
((rashika.singh@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。